Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-ranging study of fluticasone propionate dry powder inhaler in severe persistent asthma requiring oral corticosteroids
2011-005030-19Phase 2Completed
- Sponsor
- Vectura
- Start
- Jun 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of fluticasone propionate in severe asthma (3 arms), sponsored by Vectura. Primary endpoint: Mean Prednisone/prednisolone Dose for Analysis (PDA). Started Jun 2012; status: completed.
02
Drugs
fluticasone propionate
03
Conditions
severe asthma
Beyond the preview
Go deeper on 2011-005030-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005030-19.